"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," BioNTech CEO Ugur Sahin said Tuesday.

"Our war against the virus is not over yet, but this week we're taking a major step toward our eventual victory," Health and Human Services Secretary Alex Azar said.

Monday on Political Rewind: The first batch of COVID-19 vaccines is headed to hundreds of distribution centers in all 50 states.

A portion of the first coronavirus vaccines have been designated to go to Indian Country, but some tribes are skeptical about the federal government's ability to deliver and distribute the vaccines.

The Food and Drug Administration's authorization of a COVID-19 vaccine could come in a day or two, a member of an FDA expert panel says. But he says it may be late 2021 before normalcy returns.

False claims about COVID-19 vaccines are spreading widely on social media, researchers warn. They could undermine public health efforts to curb the pandemic.

Two National Health Service workers with long histories of severe allergies received the Pfizer, BioNTech coronavirus vaccine Tuesday. Both are now recovering after bad reactions to the dose.

Georgia expects to receive several hundred thousand doses of COVID vaccines this month for its initial distribution, the state Public Health commissioner said Tuesday.

The first groups to get shots will be health care workers and residents and staff of long-term care facilities, said the commissioner, Dr. Kathleen Toomey, at a news conference at the state Capitol.

Some Americans say they don't want to be vaccinated against the coronavirus. NPR's Ari Shapiro talks with the Ad Council's CEO about public health messaging and ways to reach vaccine skeptics.

Mass vaccinations will start less than a week after the U.K. approved the new drug. Welsh First Minister Mark Drakeford says it could start "a long path back to normality."

Experts say low-risk people in the U.S. will likely be immunized before many high-risk people in poor countries.

A British regulatory agency approved the Pfizer/BioNTech vaccine Wednesday. It could be dispersed within days to the neediest people, government officials said.

Heidi Larson, the director of the Vaccine Confidence Project, has travelled the world studying vaccine misinformation. Simply put, she says, a bad vaccine is "not in anyone's interest."

Moncef Slaoui, the chief scientific adviser for Operation Warp Speed, says that some Americans could start receiving a COVID-19 vaccine by the second week of December.

PBS Newshour correspondent John Yang reflects on his experience participating in Moderna's coronavirus vaccine trial. "It started off with self-interest — I wanted to get the vaccine sooner," he says.